179 related articles for article (PubMed ID: 21774563)
1. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Fraser IS; Parke S; Mellinger U; Machlitt A; Serrani M; Jensen J
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):258-69. PubMed ID: 21774563
[TBL] [Abstract][Full Text] [Related]
2. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
Fraser IS; Römer T; Parke S; Zeun S; Mellinger U; Machlitt A; Jensen JT
Hum Reprod; 2011 Oct; 26(10):2698-708. PubMed ID: 21784734
[TBL] [Abstract][Full Text] [Related]
3. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Fraser IS; Jensen J; Schaefers M; Mellinger U; Parke S; Serrani M
Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.
Yu Q; Zhou Y; Suturina L; Jaisamrarn U; Lu D; Parke S
J Womens Health (Larchmt); 2018 Oct; 27(10):1225-1232. PubMed ID: 29957101
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
Jensen JT; Parke S; Mellinger U; Machlitt A; Fraser IS
Obstet Gynecol; 2011 Apr; 117(4):777-787. PubMed ID: 21422847
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
von Schoultz B
Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
[TBL] [Abstract][Full Text] [Related]
7. Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
Wasiak R; Filonenko A; Vanness DJ; Law A; Jeddi M; Wittrup-Jensen KU; Stull DE; Siak S; Jensen JT
J Womens Health (Larchmt); 2013 Apr; 22(4):378-84. PubMed ID: 23586801
[TBL] [Abstract][Full Text] [Related]
8. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Jensen JT
Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
[TBL] [Abstract][Full Text] [Related]
10. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
Micks EA; Jensen JT
Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
[TBL] [Abstract][Full Text] [Related]
11. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
[TBL] [Abstract][Full Text] [Related]
12. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest.
Rafie S; Borgelt L; Koepf ER; Temple-Cooper ME; Lehman KJ
Int J Womens Health; 2013; 5():313-21. PubMed ID: 23788843
[TBL] [Abstract][Full Text] [Related]
13. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
Nelson A; Parke S; Makalova D; Serrani M; Palacios S; Mellinger U
Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):264-73. PubMed ID: 23651474
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
Zeun S; Lu M; Uddin A; Zeiler B; Morrison D; Blode H
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under.
Jensen JT; Bitzer J; Nappi RE; Ahlers C; Bannemerschult R; Parke S
Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):98-105. PubMed ID: 32162555
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
[TBL] [Abstract][Full Text] [Related]
18. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
19. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
Calaf J; Lete I; Canals I; Crespo C; Espinós B; Cristóbal I
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():24-31. PubMed ID: 25462215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
